Results 51 to 60 of about 13,599 (199)

Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemia

open access: yesJournal of Lipid Research, 2004
Decreased HDL-cholesterol (HDL-C) and familial combined hyperlipidemia (FCHL) are the two most common familial dyslipidemias predisposing to premature coronary heart disease (CHD).
Heidi E. Lilja   +10 more
doaj   +1 more source

Paradoxical effect of lipid lowering therapy in homozygous familial hypercholesterolemia: Atherosclerotic plaque calcifications and increased cardiovascular events

open access: yesRevista Portuguesa de Cardiologia, 2022
Tiziana Sampietro   +3 more
doaj   +1 more source

Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity

open access: yesJournal of Lipid Research, 2020
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has resulted in the death of more than 328,000 persons worldwide in the first 5 months of 2020.
Stephen L. Sturley   +6 more
doaj   +1 more source

Lipoprotein(a) in familial hypercholesterolemia: Tips from family history

open access: yesRevista Portuguesa de Cardiologia, 2021
Beatrice Dal Pino   +4 more
doaj   +1 more source

Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing

open access: yes, 2008
Michel FarnierPoint Médical, Dijon, FranceAbstract: Mixed dyslipidemia is a common lipid disorder characterized by the presence of an atherogenic lipoprotein phenotype due to abnormalities in various atherogenic and antiatherogenic lipoproteins ...
Michel Farnier
core  

FREQUENCY OF CO-MORBIDITIES ASSOCIATED WITH SPINAL CORD INJURY

open access: yesPakistan Armed Forces Medical Journal, 2015
Objective: To determine the frequencies of comorbidities (dyslipidemias, diabetes mellitus, and hypertension) in patients with spinal cord injury (SCI) of duration > 1 year. Study Design: Case control.
Aisha Ayyub   +4 more
doaj   +2 more sources

Lipoprotein(a) apheresis restores coronary microcirculation in refractory angina

open access: yesRevista Portuguesa de Cardiologia, 2022
Francesco Sbrana   +5 more
doaj   +1 more source

Difference in prostate cancer incidence around sixty years: effects of age and metabolic diseases

open access: yesCancer Medicine, 2018
We examined the risk of prostate cancer in the Korean population stratified on the basis of age group and risk based on metabolic diseases, using National Health Insurance System (NHIS) data.
Jin Bong Choi   +4 more
doaj   +1 more source

Managing dyslipidemia in chronic kidney disease: a comprehensive overview of evidence and recommendations [PDF]

open access: yesThe Korean Journal of Internal Medicine
Patients with chronic kidney disease (CKD) have a significantly increased risk of developing cardiovascular disease (CVD), making dyslipidemia management a critical component of cardiovascular risk reduction in this population.
Ji Yoon Kim, Suk Min Chung, Nam Hoon Kim
doaj   +1 more source

Genetic dyslipidemias

open access: yesAnnales d'Endocrinologie
Although genetic factors strongly influence lipid metabolism, genetic dyslipidemias refer to specific monogenic defects that significantly alter the function of proteins involved in lipid metabolism. Familial hypercholesterolemia results from mutations in the genes coding for LDL-receptor, apolipoprotein B100 (apoB100), PCSK9, or LDLRAP1.
openaire   +2 more sources

Home - About - Disclaimer - Privacy